Pēdējā atjaunošana :
22/08/2024
Infostab
Saraksti
Kopsavilkums
Meklēt saderības
Y-savienojuma saderības tabula
Literatūras saraksts
pētniecības grupas
valistab
plakāts
Savienojumi
sponsori
Autori
Lietošanas instrukcija
Newsletter
Trastuzumab
Oriģinālais nosaukums
Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām
Herceptin
Amerikas Savienotās Valstis, Apvienotie Arābu Emirāti, Argentīna, Austrālija, Austrija, Beļģija, Brazīlija, Čīle, Dānija, Ēģipte, Ekvadora, Francija, Grieķija, Holande, Irāna, Īrija, Islande, Itālija, Japāna, Jaunzēlande, Kanāda, Kolumbija, Lielbritānija, Luksemburga, Malaizija, Maroka, Meksika, Norvēģija, Peru, Polija, Portugāle, Rumānija, Saūda Arābija, Somija, Spānija, Šveice, Turcija, Ungārija, Vācija, Zviedrija
Herclon
Peru
Hertraz
Čīle
Herzuma
Amerikas Savienotās Valstis, Beļģija, Francija, Lielbritānija, Spānija, Vācija
Kanjinti
Beļģija, Lielbritānija, Spānija, Vācija
Trastuzumab Baxter
Jaunzēlande
Trazimera
Lielbritānija
Literatūras saraksts : Trastuzumab
tips
publicēšana
2296
Laboratorija
Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
2975
plakāts
Nalenz H, Schoenhammer K, Dietel E, Heynen S.R, Grauschopf U, Mahler H.C.
In-Use stability of herceptin for subcutaneous injection with different administration materials.
ESCP 2014 2014
3077
Laboratorija
Trastuzumab (Herceptin®) – Summary of Product Characteristics
Roche 2019
3113
Grāmata
Herceptin
Compendium Suisse des m?dicaments 2010
3258
Žurnāls
Kaiser J, Krämer I.
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags.
Int J Pharm Compound 2011 ; 15, 6 : 515-520.
3343
plakāts
Vieillard V, da Silva R, Astier A, Paul M.
Physicochemical stability of diluted trastuzumab solutions stored 6 months at 4°C.
ECOP Congress, Budapest, Hungary 2012
3366
Žurnāls
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A.
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
J Pharm Sci 2012 ; DOI 10.1002 / jps.23403
3386
Žurnāls
Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A.
Long-term physico-chemical stability of diluted trastuzumab.
Int J Pharm 2013 ; 448: 101-104.
3647
Laboratorija
Trastuzumab (Herceptin® 600 mg for subcutaneous injection) - Summary of Product Characteristics
Roche 2019
3849
Žurnāls
Pabari R.M, Ryan B, Ahmad W, Ramtoola Z.
Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions.
Curr Pharm Biotech 2013 ; 14, 2: 220-225.
4163
Žurnāls
Nalenz H, K?pf E, Dietel E.
Prolonged In-Use Stability of Reconstituted Herceptin in Commercial Intravenous Bags.
Int J Pharm Compound 2018 22;5:417-423
4191
Žurnāls
Vieillard V, Astier A, Paul M.
Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at varioustemperatures.
GaBI Journal 2018
4194
Žurnāls
Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y.
In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion.
Bio Drugs 2018 32;619-625
4271
Žurnāls
Yun J, Kim J, Chung J, Hwang S-J, Park S-J.
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Adv Ther 2019
4396
Žurnāls
Lueras A, Polozova A, Asbury D, Hippenmeyer J, Litowski J, Goss M, Breslin P, Crampton S.
Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentrations and stress conditions.
GaBI Journal 2020 ; 9, 1:
4477
Žurnāls
Crampton S, Polozoxa A, Asbury D, Lueras A, Breslin P, Hippenmeyer J, Litkowski J,,Goss M.
Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentration and stress conditions.
GaBI Journal 2020 ; 9, 1: 5-13.
4493
Žurnāls
Le Guyader G, Vieillard V, Paul M.
Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion.
J Oncol Pharm Practice 2020
4649
Žurnāls
Davies L, Milligan K, Corris M, Clarke I, Dwyer P, Lee S-E, Teraoka J, Crouse-Zeineddini J, Hippenmeyer J.
Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices.
GaBI Journal 2021 ; 10, 4
4754
Žurnāls
Weiser S, Burns C, Zartler E
Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions.
J Oncol Pharm Practice 2023 ;29,3:
Mentions Légales